This report provides a comprehensive analysis of the global biodegradable type embolic microspheres market, projecting its trajectory through 2032. It examines critical applications in hemostatic embolization and the treatment of hypervascular tumors, uterine fibroids, and BPH. The study evaluates market dynamics across various types and applications, including visualization and radioactive segments, while offering detailed regional insights for the Americas, APAC, and Europe. Furthermore, it profiles key industry players and explores emerging growth opportunities driven by technological advancements and evolving healthcare needs.

Market Overview

The global Biodegradable Type Embolic Microspheres market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Clinical Indications

Biodegradable Type Embolic Microspheres are indicated for use in:

• Hemostatic embolization
• Embolization of arteriovenous malformations
• Hypervascular tumors, including:
• Uterine fibroids
• Meningiomas
• Prostate arteries for the relief of symptoms related to Benign Prostatic Hyperplasia (BPH)

Regional Market Analysis

United States

The United States market for Biodegradable Type Embolic Microspheres is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.

China

The China market for Biodegradable Type Embolic Microspheres is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.

Europe

The Europe market for Biodegradable Type Embolic Microspheres is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.

Market Segmentation

By Type

• Visualization Type
• Radioactive Type
• Environmentally Responsive Type
• Other

By Application

• Hospitals And Clinics
• Research Institution

By Geography

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on primary expert input and analysis of company coverage, product portfolios, and market penetration:

• Biocompatibles
• Nippon Kayaku
• Varian
• Next Biomedical
• Mermaid Medical
• CeloNova BioSciences
• Biosphere Medical
• Promedics AG
• Merit Medical Systems
• ABK Biomedical
• BTG Corporate
• Teleflex
• Terumo Corporation
• Tepha
• Angio Dynamics
• Occlugel
• Jiangsu Hengrui Medicine

Market Share & Strategy

• The global two largest companies occupied a significant portion of the market share in 2025.
• This report analyzes the strategies of leading global companies, focusing on their Biodegradable Type Embolic Microspheres portfolios and capabilities, market entry strategies, market positions, and geographic footprints.

About the Report

Research Scope

LP Information, Inc. (LPI)'s newest research report, the “Biodegradable Type Embolic Microspheres Industry Forecast,” reviews total world Biodegradable Type Embolic Microspheres sales in 2025. It provides a comprehensive analysis by region and market sector of projected Biodegradable Type Embolic Microspheres sales for 2026 through 2032. The report offers a detailed analysis in US$ millions, with sales broken down by region, market sector, and sub-sector.

Analytical Depth

This Insight Report provides a comprehensive analysis of the global Biodegradable Type Embolic Microspheres landscape, highlighting key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook. It breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, the study offers a nuanced view of the current state and future trajectory of the industry.

Key Questions Addressed

• What is the 10-year outlook for the global Biodegradable Type Embolic Microspheres market?
• What factors are driving Biodegradable Type Embolic Microspheres market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Biodegradable Type Embolic Microspheres market opportunities vary by end market size?
• How does Biodegradable Type Embolic Microspheres break out by Type, by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Biodegradable Type Embolic Microspheres Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Biodegradable Type Embolic Microspheres by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Biodegradable Type Embolic Microspheres by Country/Region, 2021, 2025 & 2032

  • 2.2 Biodegradable Type Embolic Microspheres Segment by Type

    • 2.2.1 Visualization Type

    • 2.2.2 Radioactive Type

    • 2.2.3 Environmentally Responsive Type

    • 2.2.4 Other

    • 2.2.5 Biodegradable Type Embolic Microspheres Sales by Type

      • 2.2.5.1 Global Biodegradable Type Embolic Microspheres Sales Market Share by Type (2021-2026)
      • 2.2.5.2 Global Biodegradable Type Embolic Microspheres Revenue and Market Share by Type (2021-2026)
      • 2.2.5.3 Global Biodegradable Type Embolic Microspheres Sale Price by Type (2021-2026)

  • 2.3 Biodegradable Type Embolic Microspheres Segment by Application

    • 2.3.1 Hospitals And Clinics

    • 2.3.2 Research Institution

    • 2.3.3 Biodegradable Type Embolic Microspheres Sales by Application

      • 2.3.3.1 Global Biodegradable Type Embolic Microspheres Sale Market Share by Application (2021-2026)
      • 2.3.3.2 Global Biodegradable Type Embolic Microspheres Revenue and Market Share by Application (2021-2026)
      • 2.3.3.3 Global Biodegradable Type Embolic Microspheres Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Biodegradable Type Embolic Microspheres Breakdown Data by Company

    • 3.1.1 Global Biodegradable Type Embolic Microspheres Annual Sales by Company (2021-2026)

    • 3.1.2 Global Biodegradable Type Embolic Microspheres Sales Market Share by Company (2021-2026)

  • 3.2 Global Biodegradable Type Embolic Microspheres Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Biodegradable Type Embolic Microspheres Revenue by Company (2021-2026)

    • 3.2.2 Global Biodegradable Type Embolic Microspheres Revenue Market Share by Company (2021-2026)

  • 3.3 Global Biodegradable Type Embolic Microspheres Sale Price by Company

  • 3.4 Key Manufacturers Biodegradable Type Embolic Microspheres Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Biodegradable Type Embolic Microspheres Product Location Distribution

    • 3.4.2 Players Biodegradable Type Embolic Microspheres Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Biodegradable Type Embolic Microspheres by Geographic Region

  • 4.1 World Historic Biodegradable Type Embolic Microspheres Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Biodegradable Type Embolic Microspheres Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Biodegradable Type Embolic Microspheres Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Biodegradable Type Embolic Microspheres Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Biodegradable Type Embolic Microspheres Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Biodegradable Type Embolic Microspheres Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Biodegradable Type Embolic Microspheres Sales Growth

  • 4.4 APAC Biodegradable Type Embolic Microspheres Sales Growth

  • 4.5 Europe Biodegradable Type Embolic Microspheres Sales Growth

  • 4.6 Middle East & Africa Biodegradable Type Embolic Microspheres Sales Growth

• 5 Americas

  • 5.1 Americas Biodegradable Type Embolic Microspheres Sales by Country

    • 5.1.1 Americas Biodegradable Type Embolic Microspheres Sales by Country (2021-2026)

    • 5.1.2 Americas Biodegradable Type Embolic Microspheres Revenue by Country (2021-2026)

  • 5.2 Americas Biodegradable Type Embolic Microspheres Sales by Type (2021-2026)

  • 5.3 Americas Biodegradable Type Embolic Microspheres Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Biodegradable Type Embolic Microspheres Sales by Region

    • 6.1.1 APAC Biodegradable Type Embolic Microspheres Sales by Region (2021-2026)

    • 6.1.2 APAC Biodegradable Type Embolic Microspheres Revenue by Region (2021-2026)

  • 6.2 APAC Biodegradable Type Embolic Microspheres Sales by Type (2021-2026)

  • 6.3 APAC Biodegradable Type Embolic Microspheres Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Biodegradable Type Embolic Microspheres by Country

    • 7.1.1 Europe Biodegradable Type Embolic Microspheres Sales by Country (2021-2026)

    • 7.1.2 Europe Biodegradable Type Embolic Microspheres Revenue by Country (2021-2026)

  • 7.2 Europe Biodegradable Type Embolic Microspheres Sales by Type (2021-2026)

  • 7.3 Europe Biodegradable Type Embolic Microspheres Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Biodegradable Type Embolic Microspheres by Country

    • 8.1.1 Middle East & Africa Biodegradable Type Embolic Microspheres Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Biodegradable Type Embolic Microspheres Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Biodegradable Type Embolic Microspheres Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Biodegradable Type Embolic Microspheres Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Biodegradable Type Embolic Microspheres

  • 10.3 Manufacturing Process Analysis of Biodegradable Type Embolic Microspheres

  • 10.4 Industry Chain Structure of Biodegradable Type Embolic Microspheres

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Biodegradable Type Embolic Microspheres Distributors

  • 11.3 Biodegradable Type Embolic Microspheres Customer

• 12 World Forecast Review for Biodegradable Type Embolic Microspheres by Geographic Region

  • 12.1 Global Biodegradable Type Embolic Microspheres Market Size Forecast by Region

    • 12.1.1 Global Biodegradable Type Embolic Microspheres Forecast by Region (2027-2032)

    • 12.1.2 Global Biodegradable Type Embolic Microspheres Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Biodegradable Type Embolic Microspheres Forecast by Type (2027-2032)

  • 12.7 Global Biodegradable Type Embolic Microspheres Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Biocompatibles

    • 13.1.1 Biocompatibles Company Information

    • 13.1.2 Biocompatibles Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.1.3 Biocompatibles Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Biocompatibles Main Business Overview

    • 13.1.5 Biocompatibles Latest Developments

  • 13.2 Nippon Kayaku

    • 13.2.1 Nippon Kayaku Company Information

    • 13.2.2 Nippon Kayaku Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.2.3 Nippon Kayaku Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Nippon Kayaku Main Business Overview

    • 13.2.5 Nippon Kayaku Latest Developments

  • 13.3 Varian

    • 13.3.1 Varian Company Information

    • 13.3.2 Varian Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.3.3 Varian Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Varian Main Business Overview

    • 13.3.5 Varian Latest Developments

  • 13.4 Next Biomedical

    • 13.4.1 Next Biomedical Company Information

    • 13.4.2 Next Biomedical Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.4.3 Next Biomedical Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Next Biomedical Main Business Overview

    • 13.4.5 Next Biomedical Latest Developments

  • 13.5 Mermaid Medical

    • 13.5.1 Mermaid Medical Company Information

    • 13.5.2 Mermaid Medical Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.5.3 Mermaid Medical Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Mermaid Medical Main Business Overview

    • 13.5.5 Mermaid Medical Latest Developments

  • 13.6 CeloNova BioSciences

    • 13.6.1 CeloNova BioSciences Company Information

    • 13.6.2 CeloNova BioSciences Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.6.3 CeloNova BioSciences Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 CeloNova BioSciences Main Business Overview

    • 13.6.5 CeloNova BioSciences Latest Developments

  • 13.7 Biosphere Medical

    • 13.7.1 Biosphere Medical Company Information

    • 13.7.2 Biosphere Medical Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.7.3 Biosphere Medical Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Biosphere Medical Main Business Overview

    • 13.7.5 Biosphere Medical Latest Developments

  • 13.8 Promedics AG

    • 13.8.1 Promedics AG Company Information

    • 13.8.2 Promedics AG Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.8.3 Promedics AG Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Promedics AG Main Business Overview

    • 13.8.5 Promedics AG Latest Developments

  • 13.9 Merit Medical Systems

    • 13.9.1 Merit Medical Systems Company Information

    • 13.9.2 Merit Medical Systems Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.9.3 Merit Medical Systems Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Merit Medical Systems Main Business Overview

    • 13.9.5 Merit Medical Systems Latest Developments

  • 13.10 ABK Biomedical

    • 13.10.1 ABK Biomedical Company Information

    • 13.10.2 ABK Biomedical Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.10.3 ABK Biomedical Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 ABK Biomedical Main Business Overview

    • 13.10.5 ABK Biomedical Latest Developments

  • 13.11 BTG Corporate

    • 13.11.1 BTG Corporate Company Information

    • 13.11.2 BTG Corporate Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.11.3 BTG Corporate Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 BTG Corporate Main Business Overview

    • 13.11.5 BTG Corporate Latest Developments

  • 13.12 Teleflex

    • 13.12.1 Teleflex Company Information

    • 13.12.2 Teleflex Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.12.3 Teleflex Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 Teleflex Main Business Overview

    • 13.12.5 Teleflex Latest Developments

  • 13.13 Terumo Corporation

    • 13.13.1 Terumo Corporation Company Information

    • 13.13.2 Terumo Corporation Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.13.3 Terumo Corporation Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 Terumo Corporation Main Business Overview

    • 13.13.5 Terumo Corporation Latest Developments

  • 13.14 Tepha

    • 13.14.1 Tepha Company Information

    • 13.14.2 Tepha Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.14.3 Tepha Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.14.4 Tepha Main Business Overview

    • 13.14.5 Tepha Latest Developments

  • 13.15 Angio Dynamics

    • 13.15.1 Angio Dynamics Company Information

    • 13.15.2 Angio Dynamics Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.15.3 Angio Dynamics Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.15.4 Angio Dynamics Main Business Overview

    • 13.15.5 Angio Dynamics Latest Developments

  • 13.16 Occlugel

    • 13.16.1 Occlugel Company Information

    • 13.16.2 Occlugel Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.16.3 Occlugel Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.16.4 Occlugel Main Business Overview

    • 13.16.5 Occlugel Latest Developments

  • 13.17 Jiangsu Hengrui Medicine

    • 13.17.1 Jiangsu Hengrui Medicine Company Information

    • 13.17.2 Jiangsu Hengrui Medicine Biodegradable Type Embolic Microspheres Product Portfolios and Specifications

    • 13.17.3 Jiangsu Hengrui Medicine Biodegradable Type Embolic Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.17.4 Jiangsu Hengrui Medicine Main Business Overview

    • 13.17.5 Jiangsu Hengrui Medicine Latest Developments

• 14 Research Findings and Conclusion